Summary & Overview
CPT 54205: Penile Plaque Exposure and Injection for Peyronie Disease
CPT code 54205 represents a surgical procedure to expose penile fibrous plaque and inject medication directly into the external penile tissues for treatment of Peyronie disease. This code captures a targeted, in-office or ambulatory surgical intervention aimed at correcting curvature from tunical plaque and is relevant to urology and sexual medicine practices nationally.
Key payers in typical coverage analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, guidance on expected sites of service, and coverage-relevant considerations that commonly affect reimbursement and utilization. The publication summarizes standard coding recognition for plaque exposure with injection, discusses common billing and site-of-service implications, and highlights areas where policy and clinical practice intersect—such as outpatient surgical versus ambulatory settings and the role of targeted injections in non-implant management of Peyronie disease.
Data not available in the input for specific payment benchmarks, associated taxonomies, and ICD-10 diagnosis mappings. The content is intended to inform coding, billing oversight, and administrative review on a national level without state-specific references.
Billing Code Overview
CPT code 54205 describes a surgical procedure for treatment of Peyronie disease in which the provider makes an incision in the external penile skin, exposes the tunical plaque, and injects medication directly into the external area of the penis. The procedure is performed to address abnormal curvature of the erect penis caused by fibrous plaque formation.
-
Service type: Surgical plaque exposure with intracavernosal/external penile injection
-
Typical site of service: Ambulatory surgical center or hospital outpatient department (procedure requires surgical exposure and targeted injection)
Clinical & Coding Specifications
Clinical Context
A 52-year-old male presents to a urology clinic with a 6-month history of progressive penile curvature and painful erections consistent with Peyronie disease. Conservative measures and oral therapy provided inadequate symptomatic relief. After evaluation including penile duplex ultrasound to localize and measure plaque and curvature, the urologist schedules an in-office or ambulatory surgical center procedure to directly expose the dorsal penile plaque and administer an intralesional medication (for example, collagenase clostridium histolyticum or other injectable agents) into the plaque. The workflow includes pre-procedure consent, surgical site marking, local or regional anesthesia, an external penile skin incision to expose the plaque, targeted injection into the plaque, hemostasis, and layered closure of the incision. Post-procedure instructions address pain control, wound care, activity restrictions, and follow-up to assess curvature improvement and wound healing. Typical monitoring may include assessment for hematoma, infection, penile numbness, or corporal injury, with return precautions and scheduled follow-up at 1–4 weeks and at 3 months for functional outcome assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal, uncomplicated service | Use when the procedure is performed without unusual circumstances and represents the provider's usual service. |